Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H Induction in Kidney Transplantation
NCT00147381Phase 3Completed
- Start
- Jan 2004
- Primary completion
- Aug 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab in kidney transplant rejection. Started Jan 2004; status: completed.
02
Drugs
alemtuzumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00147381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147381.